UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Annals of oncology, 2020-11, Vol.31 (11), p.1553-1560

2020

Volltextzugriff (PDF)

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Annals of oncology, 2015-11, Vol.26 (11), p.2280-2286

2015

Volltextzugriff (PDF)

Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer

Cancer letters, 2014-04, Vol.346 (1), p.24-33

2014

Volltextzugriff (PDF)

Circulating tumour cells—a bona fide cause of metastatic cancer

Cancer and metastasis reviews, 2014-09, Vol.33 (2-3), p.747-756

2014

Volltextzugriff (PDF)

Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV)

Annals of oncology, 2018-10, Vol.29, p.viii640-viii640

2018

Volltextzugriff (PDF)

339P Analysis of first- and second-line immunotherapy efficacy in metastatic non-small cell lung cancer with low PD-L1 expression

Annals of oncology, 2022-11, Vol.33, p.S1575

2022

Volltextzugriff (PDF)

EP13.04-05 Outcomes of Limited-Stage Extrapulmonary Small Cell Carcinoma and Small Cell Lung Cancer

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S700

2023

Volltextzugriff (PDF)

EP13.05-03 A Comparison of the Outcomes of Pulmonary versus Extrapulmonary Extensive Stage Small Cell Carcinoma

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S701

2023

Volltextzugriff (PDF)

EP08.01-002 Real-World Survival Outcomes of Patients with High PD-L1 Advanced NSCLC Who Received Chemo-Immunotherapy vs Immunotherapy

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S334-S335

2022

Volltextzugriff (PDF)

1614P Influence of cancer on COVID-19 vaccine beliefs, attitudes and uptake

Annals of oncology, 2022-09, Vol.33, p.S1280-S1280

2022

Volltextzugriff (PDF)

657PPatient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an Australian population

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an Australian population

Annals of oncology, 2019-10, Vol.30, p.v247

2019

Volltextzugriff (PDF)

657P - Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an Australian population

Annals of oncology, 2019-10, Vol.30, p.v247-v247

2019

Volltextzugriff (PDF)

369O Timing of palliative care referral and its impact on receiving aggressive end of life care in patients with metastatic non-small cell lung cancer (NSCLC) in Southwest Sydney

Annals of oncology, 2015-12, Vol.26, p.ix111-ix111

2015

Volltextzugriff (PDF)

1805TiPPilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1245PA PHASE 3 RANDOMISED TRIAL OF ADDING NITROGLYCERIN TO FIRST LINE CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: THE AUSTRALASIAN LUNG CANCER TRIALS GROUP NITRO TRIAL

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv436-iv436

2014

Volltextzugriff (PDF)

A Phase 3 Randomised Trial of Adding Nitroglycerin to First Line Chemotherapy for Advanced Non-Small Cell Lung Cancer: the Australasian Lung Cancer Trials Group Nitro Trial

Annals of oncology, 2014-09, Vol.25, p.iv436

2014

Volltextzugriff (PDF)

Outcomes of extensive stage extrapulmonary small cell cancer

Internal medicine journal, 2023-09, Vol.53 (9), p.1556-1563

2023

Volltextzugriff (PDF)

New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use

International journal of cancer, 2014-06, Vol.134 (11), p.2523-2533

2014

Volltextzugriff (PDF)

A comparison of the outcomes of pulmonary versus extrapulmonary extensive-stage small cell carcinoma

Internal medicine journal, 2024-03, Vol.54 (3), p.414-420

2024

Volltextzugriff (PDF)

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

Vaccines (Basel), 2022-05, Vol.10 (6), p.851

2022

Volltextzugriff (PDF)

Cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Results of a phase II/III, placebo-controlled, randomised trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.12019-12019

2023

Volltextzugriff (PDF)

COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers

Vaccines (Basel), 2022-08, Vol.10 (9), p.1373

2022

Volltextzugriff (PDF)

PEARL: A randomised phase 3 trial of palliative care early in advanced lung cancers (ALTG/TOGA 13/008)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.12020-12020

2022

Volltextzugriff (PDF)

Utility of multigene panel next‐generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer

Internal medicine journal, 2024-04, Vol.54 (4), p.596-601

2024

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(41)
Dissertationen
(2)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(13)
Oncology
(13)
Patients
(9)
Chemotherapy
(7)
Aged
(6)
Cancer
(6)
General & Internal Medicine
(6)
Medicine, General & Internal
(6)
Prognosis
(6)
Adult
(5)
Female
(5)
Middle Aged
(5)
Clinical Trials
(4)
Male
(4)
Quality Of Life
(4)
Retrospective Studies
(4)
Aged, 80 And Over
(3)
Antineoplastic Agents - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer

Circulating tumour cells—a bona fide cause of metastatic cancer

Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV)

339P Analysis of first- and second-line immunotherapy efficacy in metastatic non-small cell lung cancer with low PD-L1 expression

EP13.04-05 Outcomes of Limited-Stage Extrapulmonary Small Cell Carcinoma and Small Cell Lung Cancer

EP13.05-03 A Comparison of the Outcomes of Pulmonary versus Extrapulmonary Extensive Stage Small Cell Carcinoma

EP08.01-002 Real-World Survival Outcomes of Patients with High PD-L1 Advanced NSCLC Who Received Chemo-Immunotherapy vs Immunotherapy

1614P Influence of cancer on COVID-19 vaccine beliefs, attitudes and uptake

657PPatient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an Australian population

Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an Australian population

657P - Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an Australian population

369O Timing of palliative care referral and its impact on receiving aggressive end of life care in patients with metastatic non-small cell lung cancer (NSCLC) in Southwest Sydney

1805TiPPilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV)

1245PA PHASE 3 RANDOMISED TRIAL OF ADDING NITROGLYCERIN TO FIRST LINE CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: THE AUSTRALASIAN LUNG CANCER TRIALS GROUP NITRO TRIAL

A Phase 3 Randomised Trial of Adding Nitroglycerin to First Line Chemotherapy for Advanced Non-Small Cell Lung Cancer: the Australasian Lung Cancer Trials Group Nitro Trial

Outcomes of extensive stage extrapulmonary small cell cancer

New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use

A comparison of the outcomes of pulmonary versus extrapulmonary extensive-stage small cell carcinoma

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

Cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Results of a phase II/III, placebo-controlled, randomised trial

COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers

PEARL: A randomised phase 3 trial of palliative care early in advanced lung cancers (ALTG/TOGA 13/008)

Utility of multigene panel next‐generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer

Suchergebnisse filtern